Morphine

CAS 57-27-2 4 current records 1 historicalSmall Molecule

Who holds supplier records for Morphine? 4 organisations hold a current record for Morphine: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: Spain (1); not recorded for 3.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Morphine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/morphine

Reading the evidence

  • 4 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 1 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Morphine expires 12 Mar 2034. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (4)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Morphine. Country is the organisation's recorded country, not necessarily the manufacturing site.

Spain1Country not recorded for 3
  • FRANCOPIA
    CEP
  • MACFARLAN SMITH LTD
    CEP Company GMP cert on record
  • SALARS SPA
    CEP
  • ALCALIBER S.A.
    Valid CEP holder (EDQM); not necessarily the manufacturer
    SpainCEP
Need Morphine sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (4)

Certificates of Suitability on the EDQM register for Morphine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

HolderCountryCertificateIssuedEU GMP at holder's address
ALCALIBER S.A. MadridES
CEP 2007-104 - Rev 05
Morphine hydrochloride trihydrate
Jul 2026—
S.A.L.A.R.S. S.p.A. ComoIT
CEP 2009-339 - Rev 02
Morphine hydrochloride trihydrate
Jan 2026Inspected Jun 2025
Italy
FRANCOPIA ParisFR
CEP 2008-208 - Rev 05
Morphine hydrochloride trihydrate
Oct 2025—
MACFARLAN SMITH LIMITED EdinburghGB
CEP 2001-438 - Rev 08
Morphine hydrochloride trihydrate
Jun 2024—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (1)

Organisations whose Type II DMFs for Morphine are no longer active. These show a past filing, not current supply.

Show all 1 historical record
  • MALLINCKRODT INC
    Inactive DMF 11529 · filed Jul 1995

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (78 listed products contain Morphine). The latest listed patent expires 12 Mar 2034. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Morphine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL70).

Chemical identity

IUPAC name
(4R,4aR,7S,7aR,12bS)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol
Canonical SMILES
CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O
InChIKey
BQJCRHHNABKAKU-KBQPJGBKSA-N
Synonyms
Anhydrous morphine, Hydromorphone hydrochloride impurity, morphine-, IDS-NM-009, Morphia, Morphine, Morphine (anhydrous), Morphine anhydrous, Morphine extended release, Morphine polistirex, Morphium, N02AA01, Nepenthe

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Opioid Agonist
Mechanism of action
Full Opioid Agonists

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Morphine?

4 organisations hold an active US FDA Type II Drug Master File or a CEP for Morphine: FRANCOPIA, MACFARLAN SMITH LTD, SALARS SPA and ALCALIBER S.A. (Spain). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

What do the historical Morphine records mean?

1 organisation has only inactive Type II DMFs for Morphine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Morphine have a European Certificate of Suitability?

Yes. 4 organisations hold a valid CEP for Morphine on the EDQM register, including ALCALIBER S.A. Madrid (ES), S.A.L.A.R.S. S.p.A. Como (IT), FRANCOPIA Paris (FR) and MACFARLAN SMITH LIMITED Edinburgh (GB). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Morphine?

Yes. The latest patent listed for an approved US product containing Morphine expires 12 Mar 2034, across 78 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Morphine supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Morphine?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.